Abyrx said today it raised $10 million in a new equity financing round and expanded its exclusive, global license agreement with Bezwada Biomedical to include the development and production of Bezwada’s soft-tissue adhesive tech. Funds in the $10 million round came from Canaan Partners, MedEdge, BB Biotech Ventures and members of the company’s executive team, with […]
Newly formed medical device company Abyrx added a 3rd putty product to its list of FDA 510(k) clearances. Its Absorbable Hemostatic Bone Putty (AHBP) is a mechanical tamponade (bleeding control) material.
Founded in April, Abyrx was formed from the acquisition of assets from Orthocon and DRG. The Irvington, N.Y.-based company plans to expand its line of hemostasis products, according to a press release.